Back |
home / stock / dthr / dthr message board
Subject | By | Source | When |
---|---|---|---|
ReminX is an #AI powered therapeutic designed to | Spread Medic | investorshub | 03/27/2018 1:42:18 PM |
it wont be long before everyone catches on! | Spread Medic | investorshub | 03/27/2018 1:41:48 PM |
check out the company site http://www.dthera.com | budfoxfun | investorshub | 03/27/2018 1:37:42 PM |
Good morning everyone. the topic here is $DTHR: | Spread Medic | investorshub | 03/27/2018 1:09:15 PM |
$DTHR's Reminiscence Therapy can be such a big | Let's Roll | investorshub | 03/27/2018 12:52:27 PM |
That was a great update Jedi. | Let's Roll | investorshub | 03/27/2018 12:51:19 PM |
Dthera Developing First Digital Therapeutics to Address Issues | jedijazz | investorshub | 03/27/2018 12:29:49 PM |
Check out this video https://www.facebook.com/reminiscencetherapy/videos/1068030 | Let's Roll | investorshub | 03/27/2018 10:42:30 AM |
That is a huge problem for those suffering | Let's Roll | investorshub | 03/27/2018 10:41:31 AM |
Dthera Sciences top product for release in MAY | jedijazz | investorshub | 03/26/2018 7:53:23 PM |
next generation of health care having a huge | budfoxfun | investorshub | 03/26/2018 7:25:11 PM |
Calling for a run up this week on $DTHR | jedijazz | investorshub | 03/26/2018 6:55:09 PM |
worldwide cost of dementia in 2018 is estimated | budfoxfun | investorshub | 03/26/2018 6:44:37 PM |
Very nice Let's Roll! Reminiscence Therapy (RT) is | jedijazz | investorshub | 03/26/2018 6:42:44 PM |
A massive demographic shift is underway in the | Spread Medic | investorshub | 03/26/2018 6:25:10 PM |
Nice Bud! check out this video with the | jedijazz | investorshub | 03/26/2018 6:23:37 PM |
2018 Alzheimer's Disease Facts and Figures report stated | jedijazz | investorshub | 03/26/2018 6:22:56 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK , June 5, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lists of downgrades from its respective OTCQX® and OTCQB® markets and Caveat Emptor Desig...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing in neurodegenerative diseases, today announced that its Board of Directors has initiated a process to pursue a range of potential strategic transactions to en...
SAN DIEGO, CA / ACCESSWIRE / February 25, 2019 / Dthera ™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized in neurodegenerative diseases, is pleased to announce that it has entered into an exclusivity agreement with a company headquartered in Japan for develo...